Dear all,
> I want some information about costs, availability, medical team opinion about
> pharmaceutical intervention, and how to make a pharmaceutical care in
> internal medicine setting.
It would be interesting to look at the effects of a hospital installed
PhC program for asthma. Basically asthma is a disease where
therapeutic outcome monitoring (TOM) can be applied, and
patients can be taught to perform self-management on the basis of
their PEV.
I can see one major problem however. PhC is not a one-time form
of care. There has to be some continuity in order for it to be
effective, and I am not sure if that continuity can be insured in a
hospital setting. That depends on the local health system, I
presume.
In general, in most programs, the savings come from a decreased
rate of hospital admissions. More important to the patient however,
is a better management of the disease, bringing the number of
nightly awakenings, and asthma attacks down.
The TOM process in asthma has been developed by Doug Hepler,
at the University of Florida, and as far as I can see no basic
changes to the concept have been made to date.
For more information for South American countries, it seems best
to contact him at hepler@cop3.health.ufl.edu.
Foppe
**************************************************************
J.W.F. van Mil, Snailmail: Margrietlaan 1, NL9471 CT Zuidlaren
Just a gay pharmacist in science and practice
**************************************************************
|